down arrow

Renascience, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3981100005
JPY
1,730.00
0.00 (0.00%)

Dec 12

TKS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Taiko Pharmaceutical Co., Ltd.
Solasia Pharma KK
Nippon Chemiphar Co., Ltd.
BrightPath Biotherapeutics Co., Ltd.
Wakamoto Pharmaceutical Co., Ltd.
Healios KK
Fuso Pharmaceutical Industries Ltd.
RaQualia Pharma, Inc.
Renascience, Inc.
SymBio Pharmaceuticals Ltd.
CanBas Co., Ltd.
Why is Renascience, Inc. ?
1
Poor Management Efficiency with a low ROE of 0%
  • The company has reported losses. Due to this company has reported negative ROE
2
Poor long term growth as Operating profit has grown by an annual rate 4.82% of over the last 5 years
  • NET SALES(Q) At JPY 10 MM has Fallen at -75%
  • RAW MATERIAL COST(Y) Grown by 13.22% (YoY)
  • OPERATING PROFIT(Q) Lowest at JPY -102.27 MM
3
With ROE of -10.23%, it has a attractive valuation with a 13.77 Price to Book Value
  • Over the past year, while the stock has generated a return of 484.46%, its profits have risen by 30.7%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Renascience, Inc. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Renascience, Inc.
484.46%
2.91
129.56%
Japan Nikkei 225
27.57%
1.07
25.74%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-1.61%
EBIT Growth (5y)
4.82%
EBIT to Interest (avg)
-238.51
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.05
Sales to Capital Employed (avg)
0.08
Tax Ratio
21.10%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
13.77
EV to EBIT
-122.43
EV to EBITDA
-122.48
EV to Capital Employed
-274.84
EV to Sales
165.00
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-10.23%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company
NET PROFIT(HY)

Higher at JPY -106.38 MM

-26What is not working for the Company
NET SALES(Q)

At JPY 10 MM has Fallen at -75%

RAW MATERIAL COST(Y)

Grown by 13.22% (YoY

OPERATING PROFIT(Q)

Lowest at JPY -102.27 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -1,022.74 %

PRE-TAX PROFIT(Q)

Lowest at JPY -66.63 MM

NET PROFIT(Q)

Lowest at JPY -66.88 MM

EPS(Q)

Lowest at JPY -5.26

Here's what is not working for Renascience, Inc.
Net Sales
At JPY 10 MM has Fallen at -75%
Year on Year (YoY)
MOJO Watch
Near term sales trend is extremely negative

Net Sales (JPY MM)

Pre-Tax Profit
At JPY -66.63 MM has Fallen at -82.75%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (JPY MM)

Net Profit
At JPY -66.88 MM has Fallen at -81.01%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (JPY MM)

Operating Profit
Lowest at JPY -102.27 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (JPY MM)

Operating Profit Margin
Lowest at -1,022.74 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit
Lowest at JPY -66.63 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (JPY MM)

Net Profit
Lowest at JPY -66.88 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (JPY MM)

EPS
Lowest at JPY -5.26
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (JPY)

Raw Material Cost
Grown by 13.22% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."